Surgery for Obesity and Related Diseases
Volume 6, Issue 6 , Pages 601-607 , November 2010

Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers

  • Matthew L. Maciejewski, Ph.D.

      Affiliations

    • Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, North Carolina
    • Division of General Internal Medicine, Department of Medicine, Duke University, Durham, North Carolina
    • Corresponding Author InformationCorrespondence: Matthew L. Maciejewski, Ph.D., Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 508 Fulton Street, Mail Stop 152, Durham, NC 27705
    • ,
  • Edward H. Livingston, M.D., M.S.

      Affiliations

    • Division of Gastrointestinal and Endocrine Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
    • Veterans Affairs North Texas Health Care System, Dallas, Texas
    • Biomedical Engineering, University of Texas, Arlington, Texas
    • ,
  • Leila C. Kahwati, M.D., M.P.H.

      Affiliations

    • National Center for Health Promotion and Disease Prevention, Office of Patient Care Services, Veterans Health Administration, Department of Veterans Affairs, Durham, North Carolina
    • ,
  • William G. Henderson, Ph.D.

      Affiliations

    • Denver Veterans Affairs Medical Center, Denver, Colorado
    • Department of Biostatistics, University of Colorado School of Public Health, Aurora, Colorado
    • Colorado Health Outcomes Program, University of Colorado, Aurora, Colorado
    • ,
  • Andrew L. Kavee, M.A.

      Affiliations

    • Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, North Carolina
    • ,
  • David E. Arterburn, M.D., M.P.H.

      Affiliations

    • Group Health Research Institute, Seattle, Washington
    • Department of Medicine, Division of General Internal Medicine, University of Washington, Seattle, Washington

Received 6 November 2009 ,Accepted 11 July 2010.

References 

  1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529
  2. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139:933–949
  3. Quesenberry CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466–472
  4. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes (Lond). 2005;29:334–339
  5. Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. Can Med Assoc J. 1999;160:483–488
  6. Bell JF, Zimmerman FJ, Arterburn DE, Maciejewski ML. Healthcare Expenditures of Overweight and Obese Males and Females by Age Cohort. Obesity. 2010 May 13;Epub
  7. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–559
  8. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2693
  9. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752
  10. Arterburn D, Schauer DP, Wise RE, et al. Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009;19:184–189
  11. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737
  12. Nguyen NT, Varela E, Sabio A, Tran CL, Stamos M, Wilson SE. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203:24–29
  13. Zlabek JA, Grimm MS, Larson CJ, Mathiason MA, Lambert PJ, Kothari SN. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis. 2005;1:537–542
  14. Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2002;16:1027–1031
  15. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care (National VA Surgical Quality Improvement Program). Ann Surg. 1998;228:491–507
  16. Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg. 2002;137:20–27
  17. Livingston EH, Arterburn D, Schifftner TL, Henderson WG, DePalma RG. National Surgical Quality Improvement Program analysis of bariatric operations: modifiable risk factors contribute to bariatric surgical adverse outcomes. J Am Coll Surg. 2006;203:625–633
  18. Arterburn DE, Livingston EH, Schifftner T, et al. Changes in survival associated with bariatric surgery in VA medical centers. Arch Surg. 2009;144:914–920
  19. Maciejewski ML, Liu CF, Derleth A, McDonell M, Anderson S, Fihn SD. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health Serv Res. 2005;40:887–904
  20. Maciejewski ML, Liu CF, Fihn SD. Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes. Diabetes Care. 2009;32:75–80
  21. Fan VS, Maciejewski ML, Liu CF, McDonell M, Fihn SD. Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Serv Outcomes Res Methodol. 2006;6:21–36
  22. Maciejewski ML, Bryson CL, Perkins M, et al. Increasing copayments and adherence to diabetes, hypertension and hyperlipidemic medications. Am J Manag Care. 2010;16:e20–e34
  23. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162:2061–2069
  24. Nguyen NT, Varela JE, Sabio A, Naim J, Stamos M, Wilson SE. Reduction in prescription medication costs after laparoscopic gastric bypass. Am Surg. 2006;72:853–856
  25. Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg. 2004;8:983–987

 Supported by the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs (IIR 05-201) and has been reviewed and approved by the Surgical Quality Data Use Group (SQDUG), Office of Patient Care Services.

 The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, Duke University, University of Texas Southwestern Medical Center, University of Texas, University of Colorado, Group Health Research Institute, or University of Washington.

PII: S1550-7289(10)00596-4

doi: 10.1016/j.soard.2010.07.005

Surgery for Obesity and Related Diseases
Volume 6, Issue 6 , Pages 601-607 , November 2010

Article Tools

* Image Usage & Resolution